Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy.
第一作者:
Mudita,Pincha
第一单位:
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, 30625, Germany.
作者:
主题词
动物(Animals);生物技术(Biotechnology);印迹法, 蛋白质(Blotting, Western);细胞系(Cell Line);低温保存(Cryopreservation);细胞因子类(Cytokines);DNA引物(DNA Primers);树突细胞(Dendritic Cells);流式细胞术(Flow Cytometry);荧光素类(Fluoresceins);基因, RAG-1(Genes, RAG-1);遗传载体(Genetic Vectors);人类(Humans);免疫疗法(Immunotherapy);白细胞介素受体公共γ亚单位(Interleukin Receptor Common gamma Subunit);慢病毒属(Lentivirus);黑色素瘤(Melanoma);膜蛋白质类(Membrane Proteins);小鼠(Mice);小鼠, 基因敲除(Mice, Knockout);肽碎片(Peptide Fragments);琥珀酰亚胺类(Succinimides)
DOI
10.1089/hgtb.2011.170
PMID
22428979
发布时间
2021-10-21
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文